Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

Clinical trial NCT07520045 · RECRUITING

Trial details

NCT number: NCT07520045
Sponsor: Osijek University Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetic Retinopathy (DR)Diabetic Macular Edema (DME)

Start date: 2026-03-12
Primary completion: 2027-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.